The sodium-glucose cotransporter 2 inhibitor luseogliflozin can suppress muscle atrophy in Db/Db mice by suppressing the expression of &lt;i&gt;foxo1&lt;/i&gt;

The sodium-glucose cotransporter 2 inhibitor luseogliflozin can suppress muscle atrophy in Db/Db mice by suppressing the expression of <i>foxo1</i>

Takuro Okamura(Kyoto Prefectural University of Medicine), Michiaki Fukui(Kyoto Prefectural University of Medicine)

Journal of Clinical Biochemistry and Nutrition

January 1, 2019

Cited by 28

No related papers found

Powered by citation graph analysis